Rise of the Machines
A ‘robot scientist’, capable of independently carrying out drug screening research, has been developed by UK researchers.
Stephanie Sutton |
First there was Adam, the first robot to autonomously make a scientific discovery. Adam hypothesised and experimentally confirmed the functions of genes in yeast, and now Adam’s successor, Eve, is turning her attention to drug development (1). Eve can automate library-screening, hit-confirmation, and lead generation through cycles of quantitative structure-activity relationship learning and testing. The system’s creators, from Cambridge University and the University of Manchester, hope that Eve will help speed up the development of drugs for neglected tropical diseases.
Read the full article now
Log in or register to read this article in full and gain access to The Medicine Maker’s entire content archive. It’s FREE and always will be!
Or register now - it’s free and always will be!
You will benefit from:
- Unlimited access to ALL articles
- News, interviews & opinions from leading industry experts
- Receive print (and PDF) copies of The Medicine Maker magazine
Or Login via Social Media
By clicking on any of the above social media links, you are agreeing to our Privacy Notice.